History
  • No items yet
midpage
Bartoli v. APP Pharmaceuticals, Inc.
842 F. Supp. 2d 479
E.D.N.Y
2012
Read the full case

Background

  • MDL involving generic pamidronate and ONJ was transferred to this court on December 2, 2009.
  • Cases involve plaintiffs alleging ONJ or increased ONJ risk from generic pamidronate; claims span design defect, failure to warn, negligence, and warranties.
  • By January 6, 2012, nine plaintiffs remained after 125 dismissed following Mensing's ruling and related stay.
  • Defendants APP Pharmaceuticals, Ben Venue Laboratories, Hospira, Sandoz, and Teva moved to dismiss remaining claims under Rule 12(b)(6).
  • Court applied Mensing to hold all remaining state-law claims preempted and granted dismissal.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Preemption of failure to warn claims Pls argue state law duty to warn survives federal sameness. Mens ing requires sameness, preempts warnings claims. Preempted; dismissed.
Preemption of design defect claims Design defect independent of labeling duty exists. Mensing extends to design; cannot alter design. Preempted; dismissed.
Preemption of negligence claims Negligence includes testing/manufacturing independent of labeling. Negligence claims are essentially failure to warn under Mensing. Preempted; dismissed.
Preemption of breach of express warranty Express warranties stand apart from labeling changes. Labels cannot be changed unilaterally; preempted by sameness. Preempted; dismissed.
Preemption of breach of implied warranty Implied warranties rely on design/safety benefits. Design-related claims preempted under Mensing. Preempted; dismissed.

Key Cases Cited

  • Mensing, Inc. v. plaintiff, 131 S. Ct. 2567 (2011) (failure to warn labels must be same as brand-name)
  • Wyeth v. Levine, 555 U.S. 555 (2009) (federal duty to sameness preempts state-law warnings)
  • Freightliner Corp. v. Myrick, 514 U.S. 280 (1995) (implied preemption when state and federal conflict)
  • U.S. Smokeless Tobacco Mfg. Co. v. City of New York, 703 F. Supp. 2d 329 (S.D.N.Y. 2010) (preemption analysis for state tort claims against manufacturers)
  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (rejects threadbare pleadings; plausibility standard)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (heightened pleading standard; plausibility)
Read the full case

Case Details

Case Name: Bartoli v. APP Pharmaceuticals, Inc.
Court Name: District Court, E.D. New York
Date Published: Jan 30, 2012
Citation: 842 F. Supp. 2d 479
Docket Number: Case No.: 10-CV-1860(KAM)(SMG); No. 09-MD-2120(KAM)(SMG)
Court Abbreviation: E.D.N.Y